UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Ministry advises smokers to stop using e-cigarettes
The Ministry of Health and Welfare has recommended smokers who use e-cigare...
by Lee Han-soo
|
2019-09-23 16:55
라인
FDA recommends Kolon to remanufacture Invossa’s second fluid
The U.S. Food and Drug Administration has recommended Kolon TissueGene to r...
by Jeong Sae-im
|
2019-09-23 15:32
라인
Dong-A ST's Aranesp biosimilar gets nod in Japan
Dong-A ST said that Sanwa Kagaku Kenkyusho (SKK), its Japanese partner, has...
by Lee Han-soo
|
2019-09-23 15:31
라인
Drug firms uncertain about pricing of quadrivalent flu vaccines
As the 2019-2020 flu season approaches, pharmaceutical firms are engaging i...
by Jeong Sae-im
|
2019-09-23 14:52
라인
Vuno, Daegu Fatima Hospital to cooperate on AI-based medical service
Vuno said that it would collaborate with Daegu Fatima Hospital to establish...
by Lee Han-soo
|
2019-09-23 14:52
라인
Roche’s Tecentriq becomes 1st immunotherapy to win indication for SCLC
Roche Korea has received approval from the Ministry of Food and Drug Safety...
by Lee Han-soo
|
2019-09-23 13:28
라인
‘Diabetes treatment Forxiga born as new heart drug in DAPA-HF study’
“The DAPA-HF trial results announced in the recent European Society of Card...
by Kim Yun-mi
|
2019-09-23 11:45
라인
‘Daewoong’s diabetes therapy proves superior blood-sugar-lowering effect to existing drugs’
Daewoong Pharmaceutical said its poster session on phase 1 clinical trial o...
by Lee Han-soo
|
2019-09-20 17:51
라인
Sex-specific strategies needed to prevent dementia
Men and women have different cardiometabolic risk factors that could lower ...
by Kwak Sung-sun
|
2019-09-20 14:30
라인
Dongwha could lose ₩60 billion sales as GSK ends deal
Dongwha Pharmaceutical faces a steep decrease in sales as GSK Consumer Heal...
by Lee Han-soo
|
2019-09-20 14:28
라인
Novo Nordisk releases trial result for basal insulin analog injection
Novo Nordisk said it has presented the global head-to-head trial called CON...
by Lee Han-soo
|
2019-09-20 12:27
라인
Multinational pharmaceuticals continue to increase R&D spending in Korea
The Korea Research-based Pharma Industry Association (KRPIA) said that the ...
by Lee Han-soo
|
2019-09-19 17:15
라인
Hanmi unveils strong diabetes pipeline at EU meet
Hanmi Pharmaceutical said that it has confirmed the global competitiveness ...
by Lee Han-soo
|
2019-09-19 15:30
라인
Rayence launches low-dose, high-performance X-ray detector
Rayence said Thursday that it has developed a Super IGZO-based high-speed v...
by Lee Han-soo
|
2019-09-19 15:29
라인
‘Galderma Korea ran background checks on unionized workers’
The labor union of Galderma Korea, the local offshoot of a skin healthcare ...
by Jeong Sae-im
|
2019-09-19 15:18
라인
Takeda Korea labor union to ask Japanese headquarters about restructuring
Takeda Pharmaceutical Korea’s trade union, in dispute with management durin...
by Kim Yun-mi
|
2019-09-19 14:11
라인
Chong Kun Dang releases trial result for diabetes treatment
Chong Kun Dang said that it has presented a clinical trial result, which it...
by Lee Han-soo
|
2019-09-19 14:11
라인
Indian biosimilar of rituximab to undergo test in Korea
India’s largest generics drugmaker Dr. Reddy's Laboratories said it wou...
by Lee Hye-seon
|
2019-09-19 10:31
라인
'Multiple sclerosis show more severe symptoms in young people'
Researchers at Seoul National University Hospital have found young patients...
by Lee Han-soo
|
2019-09-18 18:05
라인
Korea unlikely to include hepatitis C test in state-backed health checkup
The government is unlikely to designate a hepatitis C antibody test as a he...
by Kim Yun-mi
|
2019-09-18 15:50
-
이전
91
92
93
94
95
96
97
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top